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Case report
A 75-year-old male with a prior history of  stage II colon 
cancer, coronary heart disease, hypertension, and gout pre-
sented to our hospital's emergency department with a com-
plaint of  fatigue and shortness of  breath. The subsequent 
frontal chest radiograph demonstrated a wide mediastinum 
with clear lung fields (Fig. 1). The differential diagnosis at 
that time was vast, including acute aortic disease, lympha-
denopathy (possibly metastatic), and mediastinal mass. Ba-
sic laboratory analysis, including a set of  cardiac enzyme 
markers, showed normal values. A contrast-enhanced CT 
of  the chest showed a normal-sized heart without effusion 
and no evidence of  acute aortic syndrome (Fig. 2). The 
lungs were clear, without diffuse or focal parenchymal ab-
normality. However, several large and bulky hypoattenuat-
ing mediastinal masses with internal punctate calcifications 
were seen. The largest was in the subcarinal region. 
On further review of  prior CT scans at our institution, 
dating back approximately 10 years, the mediastinal masses 
were seen to be present but slowly enlarging and growing in 
number (Fig. 3). Also noted was the fact that some of  the 
masses developed several clusters of  punctate or speckled 
calcification as they stopped enlarging. The diagnoses of  
sarcoidosis, histoplasmosis, and other granulomatous dis-
eases with calcified adenopathy were entertained. Lym-
phoma was also considered but was felt to be less likely due 
to the calcifications. The patient had a history of  stage II 
colon cancer, was status post-hemicolectomy 9 years before 
presentation, and was thought to be cured. At this time, a 
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Figure 1. 75-year-old male with amyloidosis. Axial, contrast-
enhanced CT section of the abdomen in the arterial phase 
shows a large, heterogenous, peritoneal lesion displacing 
the bowel loops centrally.
mediastinal biopsy was performed of  the subcarinal mass to 
exclude metastatic disease (Fig. 4).
Histological examination showed deposits of  eosino-
philic, hyalinized, homogeneous waxy material with sur-
rounding histiocytic and giant-cell reaction. The deposits 
were positive for crystal violet and Congo red stain. The 
histological features and special stain results were consistent 
with amyloid. Subsequent subtyping detected a peptide 
profile consistent with AL (lambda)-type amyloid 
deposition. 
The patient's care now included a hematologist, who 
suggested bone-marrow biopsy to confirm systemic amyloi-
dosis. The patient was reluctant to undergo biopsy. He con-
tinued routine followup with his primary physician and 
hematologist. The patient re-
turned approximately 5 
months later to the emergency 
department with a similar 
presentation of  fatigue and 
shortness of  breath. He denied 
fever, chills, night sweats, or 
bone pain. A CT scan of  the 
thorax without contrast again 
showed the extensive medias-
tinal amyloidomas, with 
slightly progressive internal 
punctuate calcifications (Fig. 
5). No acute findings were 
identified. The tracheal bron-
chial tree was void of  calcifica-
tions, and the lung paren-
chyma remained clear. The 
patient had no other signs or 
symptoms of  amyloidosis 
elsewhere in his body. 
   The patient's care now in-
cluded a hematologist, who 
suggested bone-marrow bi-
opsy to confirm systemic amy-
loidosis. The patient was re-
luctant to undergo biopsy. He 
continued routine followup 
with his primary physician 
and hematologist. The patient 
returned approximately 5 
months later to the emergency 
department with a similar 
presentation of  fatigue and 
shortness of  breath. He de-
nied fever, chills, night sweats, 
or bone pain. A CT scan of  
the thorax without contrast 
again showed the extensive 
mediastinal amyloidomas, 
with slightly progressive inter-
nal punctuate calcifications 
(Fig. 5). No acute findings were 
identified. The tracheal bron-
chial tree was void of  calcifica-
tions, and the lung parenchyma remained clear. The pa-
tient had no other signs or symptoms of  amyloidosis else-
where in his body. 
The patient then agreed to undergo bone-marrow biopsy 
as an outpatient, which was positive. The hematoxylin and 
eosin-stained sections revealed a hypercellular marrow infil-
trated with scattered plasma cells, which accounted for 
approximately 10-15% of  the total cellularity (Fig. 6A). 
This was confirmed by CD 138 immunostain for plasma 
cells (Fig. 6B). The in-situ hybridization for kappa and 
lambda demonstrated that the plasma cells were lambda-
restricted (Figs. 6C, D). Flow cytometry also detected an 
abnormal plasma-cell population with lambda light-chain 
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Figure 2. 75-year-old male with amyloidosis. Contrast-enhanced CT of the thorax in soft-
tissue window. A: Axial image with large and bulky lymphadenopathy in the right hilar and 
subcarinal regions. The adenopathy is homogeneously low in attenuation, with smooth con-
tours and speckled internal calcifications. B: Coronal Maximum Intensity Projection (MIP) 
image demonstrates large adenopathy with speckled calcifications in the right hilar, subcari-
nal, and right paraesophageal regions.
Figure 3. 75-year-old male with amyloidosis. A: Contrast-enhanced CT of the thorax in soft-
tissue window obtained 10 years before Fig. 2. Axial image depicts subtle subcarinal lym-
phadenopathy without calcification. B: Contrast-enhanced, axial CT image of the thorax in 
soft-tissue window obtained 5 years before Fig. 2 shows the subcarinal mass to be enlarged 
with faint punctate calcifications. There is also new right hilar lymphadenopathy.
clonality. Congo red stain of  the marrow was negative for 
amyloid. The patient was diagnosed with IgG lambda-
restricted plasma-cell myeloma. 
Discussion
Amyloidosis is a disorder resulting from extracellular 
deposition of  misfolded amyloid proteins, which are insolu-
ble linear fibrils in a β–pleated sheet configuration. The 
deposition can be localized to one organ or can involve 
multiple organs or systems, as seen in systemic amyloidosis. 
So far, 27 amyloid proteins have been associated with hu-
man disease (1), and amyloidosis is classified according to 
the precursor protein. Microscopically, amyloid appears as 
an eosinophilic material on H&E stain, usually within or 
surrounding blood-vessel walls. It shows classic apple-green 
birefringence under polarized light after Congo-red stain-
ing. Amyloid can also be detected by crystal violet or thio-
flavin T fluorescent staining, 
as well as electron 
microscopy.
   Amyloidosis can also be 
classified as either primary or 
secondary. The primary form 
(AL) of  amyloidosis is the 
most common form, with an 
estimated age-adjusted inci-
dence of  5.1 to 12.8 per mil-
lion patients (2). In AL amy-
loidosis, the amyloid is com-
posed of  both intact light 
chain and fragments of  the 
variable NH2-terminus re-
gion, which are synthesized by 
a monoclonal plasma cell 
population (3). Therefore, AL amyloidosis can occur as a 
primary disorder or in association with plasma-cell dyscra-
sia, such as plasma-cell myeloma or monoclonal gammopa-
thy of  undetermined significance (MGUS), both of  which 
share similar genetic abnormalities with primary amyloido-
sis (3). The secondary or reactive forms (AA) are related to 
chronic inflammatory conditions or tissue-destructive proc-
esses such as rheumatoid arthritis or inflammatory bowel 
disease. The precipitating protein in secondary amyloidosis 
is always the amino-acid terminus of  the acute-phase pro-
tein serum amyloid A and is identical in all patients. 
Another form of  categorization is systemic versus local-
ized disease. In localized disease, it is believed that the amy-
loid fibril protein is deposited at the site of  production, 
whereas in systemic disease, the protein is synthesized at 
distant sites and transported in the bloodstream to be de-
posited at multiple sites (4). Localized amyloidosis is less 
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Figure 5. 75-year-old male with amyloidosis. CT of the thorax without contrast taken 5 months after Fig. 2. Axial (A) and co-
ronal (B) soft-tissue window images show the extensive amyloidomas in the subcarinal, right hilar, and right paraesophageal 
regions. There is a slight increase in speckled calcifications within the amyloidomas. C: Axial image in lung window setting 
shows the mediastinal amyloidomas with normal pleura and pulmonary parenchyma, confirming the rare imaging manifesta-
tions of this disease. 
Figure 4. 75-year-old male with amyloidosis. Core biopsy of the subcarinal mass reveals the 
presence of amyloid. A: Hematoxylin and eosin stain shows the amorphous eosinophilic 
acellular material (arrows), x100. B: Apple-green birefringence under polarized light after 
Congo red stain (arrows), x100; consistent with amyloid.
common than systemic amyloidosis. Systemic disease is 
confirmed by bone-marrow biopsy and/or electrophoresis. 
Variable manifestations are seen in patients. Features of  
amyloidosis can be classically seen in the joints, kidney, 
heart, lungs, and (most commonly) gastrointestinal system 
(5). Within the thorax, the heart is the most commonly in-
volved organ, especially in primary amyloid, with wall 
thickening and systolic dysfunction. Pulmonary involve-
ment in primary disease is common. CT findings can be 
similar to those of  pneumonia, and patients typically take 
antibiotics only to have recurrent symptoms and imaging 
findings.
Pulmonary amyloidosis has three forms: tracheobron-
chial, nodular parenchymal, and alveolar septal. Alveolar 
septal is the least common of  the three but can have the 
worst prognosis; it often leads to respiratory failure. Imag-
ing can demonstrate diffuse inter- and intralobular septal 
thickening, with micronodules often in a subpleural or 
bronchovascular distribution (5, 6). Focal nodular or mass-
like lesions called amyloidomas are seen in the nodular 
type, ranging from 0.5 to 15 cm (7). Diffuse but sometimes 
interrupted calcifications of  the large airways can be seen 
in the tracheobronchial type, which is the most common. 
CT can demonstrate intraluminal nodules or (less com-
monly) diffuse thick-
ening of  the trachea 
and bronchi. 
   In our patient, the 
CT imaging findings 
were classic for local-
ized thoracic amyloi-
dosis. Typically, me-
diastinal and hilar 
lymphadenopathy are 
seen without pulmo-
nary parenchymal 
involvement (8). The 
adenopathy is homo-
geneously low in at-
tenuation, with a 
smooth contour, and 
slowly enlarges in size 
and number over a 
period of  several 
years, becoming very 
bulky (9). It is not 
uncommon to see 
stippled, speckled, or 
faint calcifications 
within the enlarged 
amyloidomas. Pick-
ford et al reported 
that 33% of  lymph 
nodes affected by 
amyloidosis have 
these characteristic 
calcifications (8). The 
significance of  the 
calcifications is uncertain. It is unknown whether they de-
velop after the lymph node has stopped enlarging or 
whether they develop due to the slow and indolent nature 
of  the disease (10). 
   Mediastinal lymphadenopathy is a rare manifestation 
of  amyloidosis. Up to 37% of  cases of  generalized primary 
and secondary amyloidosis have lymph-node involvement, 
and 75% of  patients with thoracic disease have mediastinal 
adenopathy (11, 12). Pickford et al reviewed 300 cases of  
amyloidosis. They found only nine cases of  intrathoracic 
lymphadenopathy, and systemic amyloidosis was diagnosed 
in all cases (8). Mediastinal lymphadenopathy as a localized 
form of  amyloidosis without pulmonary findings is ex-
tremely rare. To our knowledge, only eight cases have been 
described before in the English literature (10, 13-19). The 
type of  fibril obtained by biopsy has only been reported in 
three of  those cases (all AL type, as in our patient). Unfor-
tunately, bone-marrow biopsy was not reported in all the 
cases. We believe that our case is the first of  localized me-
diastinal amyloidosis to also have positive bone-marrow 
biopsy results that confirm AL systemic disease. 
As with our patient, it is believed that localized mediasti-
nal amyloidosis has a better survival rate, on average 3 
years from diagnosis, than classic systemic amyloidosis (6-
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Figure 6. 75-year-old male with amyloidosis. Bone-marrow biopsy. A: Hematoxylin and eosin stain 
reveals a hypercellular marrow infiltrated with scattered plasma cells (arrows) that account for ap-
proximately 10-15% of the total cellularity, x400. B: CD 138 immunohistochemical stain shows in-
creased plasma cells (arrow), x200. C: In situ hybridization is positive for lambda light chain (arrow), 
x200. D: The neoplastic plasma cells are negative for kappa light chain, x200. 
18 months) (10, 20). One could hypothesize that since the 
characteristic AL fibrillar protein is a fragment of  the vari-
able immunoglobulin light and/or rarely heavy chain, and 
thus different from patient to patient, this variability in the 
AL fibril could cause the difference in clinical manifestation 
and thus prognosis, even though both are technically sys-
temic diseases. The terms "localized" or "isolated" may be a 
misnomer. One could argue that localized mediastinal amy-
loidosis is a subtype of  systemic disease. Obviously, more 
cases with localized mediastinal manifestations and bone-
marrow pathologic correlation are needed to make this 
distinction. 
The differential diagnosis of  mediastinal lymphadenopa-
thy with stippled or punctate calcifications includes: meta-
static disease, sarcoidosis and other granulomatous proc-
esses, (rarely) malignant lymphoma, and amyloidosis. Low-
attenuation lymph nodes can be seen in tuberculosis and 
fungal infections. It is difficult to include amyloidosis in the 
diagnosis of  isolated mediastinal adenopathy with internal 
punctate calcifications since it is such a rare entity; however, 
radiologists should be ready to consider it as part of  the 
differential diagnosis, given the proper clinical scenario. 
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